LVW Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$661K Sell
7,214
-638
-8% -$55.8K 0.06% 183
2026
Q1
$669K Sell
7,852
-1,924
-20% -$171K 0.06% 163
2025
Q4
$773K Buy
9,776
+2,230
+30% +$175K 0.08% 120
2025
Q3
$603K Sell
7,546
-2,746
-27% -$234K 0.06% 163
2025
Q2
$936K Buy
10,292
+5,224
+103% +$477K 0.1% 118
2025
Q1
$475K Sell
5,068
-320
-6% -$28.7K 0.06% 177
2024
Q4
$490K Buy
5,388
+597
+12% +$57K 0.06% 193
2024
Q3
$497K Buy
4,791
+1,891
+65% +$193K 0.06% 186
2024
Q2
$281K Buy
+2,900
New +$268K 0.04% 239

Other funds holding CL

LVW Advisors's CL Position: Q2 2026 in Review

LVW Advisors reduced its Colgate-Palmolive (CL) stake by 8.1% in Q2 2026, selling an estimated $55.8K and leaving 7,214 shares worth $661K. The position accounts for 0.06% of the portfolio, ranked #183.

LVW Advisors first reported a position in CL in Q2 2024 and has held it in 9 quarters since. The position peaked at $936K in Q2 2025. 610 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • LVW Advisors held 7,214 shares of Colgate-Palmolive worth $661K as of Q2 2026.
  • LVW Advisors sold 638 Colgate-Palmolive shares in Q2 2026, an estimated $55.8K.
  • Colgate-Palmolive made up 0.06% of LVW Advisors's portfolio in Q2 2026, its #183 holding.
  • LVW Advisors first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 9 quarters since.
  • LVW Advisors's Colgate-Palmolive position peaked at $936K in Q2 2025.
  • 610 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.